Given the morphological and immunophenotypic overlap between ALK- ALCL and PTCL, NOS, and no clinically available biomarker to differentiate them, the diagnosis between ALK- ALCL and CD30high PTCL, NOS could be challenging. Here, ALK is linked to anaplastic large cell lymphoma.